BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 22017994)

  • 1. Closed-loop deep brain stimulation is superior in ameliorating parkinsonism.
    Rosin B; Slovik M; Mitelman R; Rivlin-Etzion M; Haber SN; Israel Z; Vaadia E; Bergman H
    Neuron; 2011 Oct; 72(2):370-84. PubMed ID: 22017994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation on demand: closing the loop on deep brain stimulation.
    Santos FJ; Costa RM; Tecuapetla F
    Neuron; 2011 Oct; 72(2):197-8. PubMed ID: 22017983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational physiology of the basal ganglia in Parkinson's disease.
    Rivlin-Etzion M; Elias S; Heimer G; Bergman H
    Prog Brain Res; 2010; 183():259-73. PubMed ID: 20696324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological studies of information processing in the normal and Parkinsonian basal ganglia: pallidal activity in Go/No-Go task and following MPTP treatment.
    Morris G; Hershkovitz Y; Raz A; Nevet A; Bergman H
    Prog Brain Res; 2005; 147():285-93. PubMed ID: 15581713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External pallidal stimulation improves parkinsonian motor signs and modulates neuronal activity throughout the basal ganglia thalamic network.
    Vitek JL; Zhang J; Hashimoto T; Russo GS; Baker KB
    Exp Neurol; 2012 Jan; 233(1):581-6. PubMed ID: 22001773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longer β oscillatory episodes reliably identify pathological subthalamic activity in Parkinsonism.
    Deffains M; Iskhakova L; Katabi S; Israel Z; Bergman H
    Mov Disord; 2018 Oct; 33(10):1609-1618. PubMed ID: 30145811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism.
    Bergman H; Wichmann T; Karmon B; DeLong MR
    J Neurophysiol; 1994 Aug; 72(2):507-20. PubMed ID: 7983515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closed-loop control of deep brain stimulation: a simulation study.
    Santaniello S; Fiengo G; Glielmo L; Grill WM
    IEEE Trans Neural Syst Rehabil Eng; 2011 Feb; 19(1):15-24. PubMed ID: 20889437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal ganglia neural responses during behaviorally effective deep brain stimulation of the subthalamic nucleus in rats performing a treadmill locomotion test.
    Shi LH; Luo F; Woodward DJ; Chang JY
    Synapse; 2006 Jun; 59(7):445-57. PubMed ID: 16521122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward closed-loop optimization of deep brain stimulation for Parkinson's disease: concepts and lessons from a computational model.
    Feng XJ; Greenwald B; Rabitz H; Shea-Brown E; Kosut R
    J Neural Eng; 2007 Jun; 4(2):L14-21. PubMed ID: 17409470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomy and physiology of the basal ganglia: implications for deep brain stimulation for Parkinson's disease.
    Kopell BH; Rezai AR; Chang JW; Vitek JL
    Mov Disord; 2006 Jun; 21 Suppl 14():S238-46. PubMed ID: 16810674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Neuronal Activity in the Motor Thalamus during GPi-DBS in the MPTP Nonhuman Primate Model of Parkinson's Disease.
    Muralidharan A; Zhang J; Ghosh D; Johnson MD; Baker KB; Vitek JL
    Brain Stimul; 2017; 10(1):126-138. PubMed ID: 27839724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of the neural mechanisms of deep brain stimulation in rodent models of Parkinson's disease.
    Chang JY; Shi LH; Luo F; Zhang WM; Woodward DJ
    Neurosci Biobehav Rev; 2008; 32(3):352-66. PubMed ID: 18035416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease.
    Goldberg JA; Boraud T; Maraton S; Haber SN; Vaadia E; Bergman H
    J Neurosci; 2002 Jun; 22(11):4639-53. PubMed ID: 12040070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model-based rational feedback controller design for closed-loop deep brain stimulation of Parkinson's disease.
    Gorzelic P; Schiff SJ; Sinha A
    J Neural Eng; 2013 Apr; 10(2):026016. PubMed ID: 23449002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurons in both pallidal segments change their firing properties similarly prior to closure of the eyes.
    Adler A; Joshua M; Rivlin-Etzion M; Mitelman R; Marmor O; Prut Y; Bergman H
    J Neurophysiol; 2010 Jan; 103(1):346-59. PubMed ID: 19864438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simulation of cortico-basal ganglia oscillations and their suppression by closed loop deep brain stimulation.
    Grant PF; Lowery MM
    IEEE Trans Neural Syst Rehabil Eng; 2013 Jul; 21(4):584-94. PubMed ID: 22695362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinated Reset Deep Brain Stimulation of Subthalamic Nucleus Produces Long-Lasting, Dose-Dependent Motor Improvements in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Non-Human Primate Model of Parkinsonism.
    Wang J; Nebeck S; Muralidharan A; Johnson MD; Vitek JL; Baker KB
    Brain Stimul; 2016; 9(4):609-17. PubMed ID: 27151601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.